Integration of all this information allows the clinicians to provide reliable risk estimates with regard to risk of dying from thyroid cancer (AJCC stage), risk of having disease recurrence (ATA risk) and initial response to therapy assessments, intra-operative findings, post-op thyroglobulin, and post-op imaging if clinically indicated. Here, TG is linked to thyroid cancer.